Corporate DealsMar 27, 2025 · 7:59pm ET
LXRXLEXICON PHARMACEUTICALS, INC.
Lexicon Pharmaceuticals Enters into Exclusive License Agreement with Novo Nordisk for LX9851
Agreement includes potential payments up to $1 billion and tiered royalties.
Corporate DealsMar 27, 2025 · 7:59pm ET
LXRXLEXICON PHARMACEUTICALS, INC.+124.7%
Lexicon Pharmaceuticals Enters into Exclusive License Agreement with Novo Nordisk for LX9851